AI-Based Clinical Trials Solution Provider Market

  • Published on 2025-11-11
  • Report Code: 1236
  • 170-350 pages
AI-Based Clinical Trials Solution Provider Market

AI-Based Clinical Trials Solution Provider Market: Segmented: By Clinical Trial Phase (Phase-I, Phase-II, Phase-III), By Therapeutic Application (Oncology, Cardiovascular Diseases, Neurological Diseases or Conditions, Metabolic Diseases, Infectious Diseases, Others), By End User (Pharmaceutical Companies, Academia, Others), And Region - Global Analysis of Market Size, Share & Trends For 2021-2022 And Forecasts To 2032

Table Of Content

 Content

  1. Executive Summary
    1. Regional Market Share
    2. Business Trends
    3.   AI-Based Clinical Trials Solution Provider: COVID-19 Outbreak
    4. Regional Trends
    5. Segmentation Snapshot
  2. Research Methodology
    1. Research Objective
    2. Research Approach
    3. Data Sourcing and Methodology 
    4. Primary Research  
    5. Secondary Research
      1.  Paid Sources
      2.  Public Sources
    6. Market Size Estimation and Data Triangulation   
  3. Market Characteristics   
    1. Market Definition
    2.   AI-Based Clinical Trials Solution Provider: COVID-19 Impact
    3. Key Segmentations
    4. Key Developments
    5. Allied Industry Data
  4. AI-Based Clinical Trials Solution Provider Market – Industry Insights
    1. Industry Segmentation
    2. COVID-19 overview on world economy
    3. Industry ecosystem Channel analysis
    4. Innovation & Sustainability
  5. Macroeconomic Indicators
  6. Recent Developments
  7. Market Dynamics
    1. Introduction
    2. Growth Drivers
    3. Market Opportunities         
    4. Market Restraints
    5. Market Trends        
  8. Risk Analysis
  9. Market Analysis   
    1. Porters Five Forces
    2. PEST Analysis          
      1. Political  
      2. Economic
      3. Social
      4. Technological
  10. AI-Based Clinical Trials Solution Provider Market
    1. Overview
    2. Historical Analysis (2016-2020)
      1. Market Size, Y-o-Y Growth (%) and Market Forecast
  11.   AI-Based Clinical Trials Solution Provider Market Size & Forecast 2022A-2032F    
    1. Overview    
    2. Key Findings
    3. Market Segmentation
      1. By Clinical Trial Phase
        1. Phase-I
        2. By Value (USD Million) 2022-2032F
        3. Market Share (%) 2022-2032F
        4. Y-o-Y Growth (%) 2022-2032F
        5. Phase-II
        6. By Value (USD Million) 2022-2032F
        7. Market Share (%) 2022-2032F
        8. Y-o-Y Growth (%) 2022-2032F
        9. Phase-III
        10. By Value (USD Million) 2022-2032F
        11. Market Share (%) 2022-2032F
        12. Y-o-Y Growth (%) 2022-2032F
      2. By Therapeutic End User
        1. Oncology
        2. By Value (USD Million) 2022-2032F
        3. Market Share (%) 2022-2032F
        4. Y-o-Y Growth (%) 2022-2032F
        5. Cardiovascular Diseases
        6. By Value (USD Million) 2022-2032F
        7. Market Share (%) 2022-2032F
        8. Y-o-Y Growth (%) 2022-2032F
        9. Neurological Diseases or Conditions
        10. By Value (USD Million) 2022-2032F
        11. Market Share (%) 2022-2032F
        12. Y-o-Y Growth (%) 2022-2032F
        13. Metabolic Diseases
        14. By Value (USD Million) 2022-2032F
        15. Market Share (%) 2022-2032F
        16. Y-o-Y Growth (%) 2022-2032F
        17. Infectious Diseases
        18. By Value (USD Million) 2022-2032F
        19. Market Share (%) 2022-2032F
        20. Y-o-Y Growth (%) 2022-2032F
        21. Others
        22. By Value (USD Million) 2022-2032F
        23. Market Share (%) 2022-2032F
        24. Y-o-Y Growth (%) 2022-2032F
      3. By End User
        1. Pharmaceutical Companies
        2. By Value (USD Million) 2022-2032F
        3. Market Share (%) 2022-2032F
        4. Y-o-Y Growth (%) 2022-2032F
        5. Academia
        6. By Value (USD Million) 2022-2032F
        7. Market Share (%) 2022-2032F
        8. Y-o-Y Growth (%) 2022-2032F
        9. Others
        10. By Value (USD Million) 2022-2032F
        11. Market Share (%) 2022-2032F
        12. Y-o-Y Growth (%) 2022-2032F
  12. North America AI-Based Clinical Trials Solution Provider Market Size & Forecast 2022A-2032F
    1. Overview    
    2. Key Findings
    3. Market Segmentation
      1. By Clinical Trial Phase
      2. By Therapeutic End User
      3. By End User
    4. Country
      1. United States
      2. Canada
  13. Europe AI-Based Clinical Trials Solution Provider Market Size & Forecast 2022A-2032F
    1. Overview    
    2. Key Findings
    3. Market Segmentation
      1. By Clinical Trial Phase
      2. By Therapeutic End User
      3. By End User
    4. Country
      1. Germany
      2. United Kingdom
      3. France
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
  14. Asia AI-Based Clinical Trials Solution Provider Market Size & Forecast 2022A-2032F
    1. Overview    
    2. Key Findings
    3. Market Segmentation
      1. By Clinical Trial Phase
      2. By Therapeutic End User
      3. By End User
    4. By Country
      1. India
      2. China
      3. South Korea
      4. Japan
      5. Rest of APAC
  15. Middle East and Africa AI-Based Clinical Trials Solution Provider Market Size & Forecast 2022A-2032F
    1. Overview    
    2. Key Findings
    3. Market Segmentation
      1. By Clinical Trial Phase
      2. By Therapeutic End User
      3. By End User
    4. Country
      1. Israel
      2. GCC
      3. North Africa
      4. South Africa
      5. Rest of Middle East and Africa
  16. Latin America AI-Based Clinical Trials Solution Provider Market Size & Forecast 2022A-2032F
    1. Overview    
    2. Key Findings
    3. Market Segmentation
      1. By Clinical Trial Phase
      2. By Therapeutic End User
      3. By End User
    4. Country
      1. Mexico
      2. Brazil
      3. Rest of Latin America
  17. Competitive Landscape
    1. Company market share, 2021
    2. Key player overview
    3. Key stakeholders
  18. Company Profiles
    1. Deep Lens Inc.
      1. Company Overview
      2. Financial Overview
      3. Key Product; Analysis
      4. Company Assessment
        1. Product Portfolio       
        2. Key Clients
        3. Market Share 
        4. Recent News & Development (Last 3 Yrs.)   
        5. Executive Team
    2. Hematology-Oncology Associates of CNY
    3. GlaxoSmithKline plc
    4. Genentech
    5. AiCure LLC
    6. Aiforia
    7. Antidote Technologies Inc.
    8. Avantor Inc.
    9. Deep 6 AI
    10. Innoplexus Consulting Services Pvt Ltd
    11. Intelligencia.ai
    12. MEDIAN Technologies
    13. Pharmaceutical Pipeline Enhancement Strategies LLC
    14. Saama Technologies Pvt Ltd
    15. Simplifai AS
    16. Other Prominent Players
  19. Appendix
  20. Consultant Recommendation
To request a free sample copy of this report, please complete the form below.

Select License Type

$ 4950

Report accessible by 1 user only

In case you require a hard copy, there will be an additional charge of $500. Please email us at [email protected] with your request.

Read all reports

Our Clients

We have been working with some Fortune 500+ clients